Literature DB >> 12554745

On the role of liver X receptors in lipid accumulation in adipocytes.

Lene K Juvet1, Sissel M Andresen, Gertrud U Schuster, Knut Tomas Dalen, Kari Anne R Tobin, Kristin Hollung, Fred Haugen, Severina Jacinto, Stine M Ulven, Krister Bamberg, Jan-Ake Gustafsson, Hilde I Nebb.   

Abstract

The pivotal role of liver X receptors (LXRs) in the metabolic conversion of cholesterol to bile acids in mice is well established. More recently, the LXRalpha promoter has been shown to be under tight regulation by peroxisome proliferator-activated receptors (PPARs), implying a role for LXRalpha in mediating the interplay between cholesterol and fatty acid metabolism. We have studied the role of LXR in fat cells and demonstrate that LXR is regulated during adipogenesis and augments fat accumulation in mature adipocytes. LXRalpha expression in murine 3T3-L1 adipocytes as well as in human adipocytes was up-regulated in response to PPARgamma agonists. Administration of a PPARgamma agonist to obese Zucker rats also led to increased LXRalpha mRNA expression in adipose tissue in vivo. LXR agonist treatment of differentiating adipocytes led to increased lipid accumulation. An increase of the expression of the LXR target genes, sterol regulatory binding protein-1 and fatty acid synthase, was observed both in vivo and in vitro after treatment with LXR agonists for 24 h. Finally, we demonstrate that fat depots in LXRalpha/beta-deficient mice are smaller than in age-matched wild-type littermates. These findings imply a role for LXR in controlling lipid storage capacity in mature adipocytes and point to an intriguing physiological interplay between LXR and PPARgamma in controlling pathways in lipid handling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554745     DOI: 10.1210/me.2001-0210

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  41 in total

1.  hCG-induced down-regulation of PPARγ and liver X receptors promotes periovulatory progesterone synthesis by macaque granulosa cells.

Authors:  Muraly Puttabyatappa; Catharine A Vandevoort; Charles L Chaffin
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

2.  Liver X receptor (LXR) regulates human adipocyte lipolysis.

Authors:  Britta M Stenson; Mikael Rydén; Nicolas Venteclef; Ingrid Dahlman; Annie M L Pettersson; Aline Mairal; Gaby Aström; Lennart Blomqvist; Victoria Wang; Johan W E Jocken; Karine Clément; Dominique Langin; Peter Arner; Jurga Laurencikiene
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

3.  Activation of LXR increases acyl-CoA synthetase activity through direct regulation of ACSL3 in human placental trophoblast cells.

Authors:  M Susanne Weedon-Fekjaer; Knut Tomas Dalen; Karianne Solaas; Anne Cathrine Staff; Asim K Duttaroy; Hilde Irene Nebb
Journal:  J Lipid Res       Date:  2010-03-10       Impact factor: 5.922

Review 4.  Minireview: liver X receptor beta: emerging roles in physiology and diseases.

Authors:  Chiara Gabbi; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2008-12-12

5.  De novo synthesis of steroids and oxysterols in adipocytes.

Authors:  Jiehan Li; Edward Daly; Enrico Campioli; Martin Wabitsch; Vassilios Papadopoulos
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

6.  Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression.

Authors:  S Fernández-Veledo; I Nieto-Vazquez; C M Rondinone; M Lorenzo
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

7.  Nuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiation.

Authors:  Flavia Q Pirih; Rosette Abayahoudian; David Elashoff; Farhad Parhami; Jeanne M Nervina; Sotirios Tetradis
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

8.  Peroxisome proliferator-activated receptor {gamma} stimulation of adipocyte ApoE gene transcription mediated by the liver receptor X pathway.

Authors:  Lili Yue; Theodore Mazzone
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

9.  Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetes.

Authors:  Jacqueline T Jonker; Yanan Wang; Willeke de Haan; Michaela Diamant; Luuk J Rijzewijk; Rutger W van der Meer; Hildo J Lamb; Jouke T Tamsma; Albert de Roos; Johannes A Romijn; Patrick C N Rensen; Johannes W A Smit
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 17.152

10.  Lipogenesis in arterial wall and vascular smooth muscular cells: regulation and abnormalities in insulin-resistance.

Authors:  Nadjiba Hamlat; Fabien Forcheron; Samia Negazzi; Peggy del Carmine; Patrick Feugier; Giampiero Bricca; Souhila Aouichat-Bouguerra; Michel Beylot
Journal:  Cardiovasc Diabetol       Date:  2009-12-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.